Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma.

Junjie ZhaoJiayu LiangYang YangGuangxi SunXingming ZhangJinge ZhaoXu HuJunru ChenSha ZhuYuchao NiYaowen ZhangJindong DaiZhipeng WangZilin WangYuhao ZengJin YaoNi ChenPengfei ShenZhenhua LiuHao Zeng

Published in: Clinical epigenetics (2022)

These results suggest that BCAM could serve as a biomarker distinguishing different tumor microenvironment phenotypes, predicting prognosis and helping therapeutic decision-making for patients with ccRCC.

Keyphrases

decision making
single cell
dna methylation
genome wide
gene expression